Lupus erythematosus

• Ampel BioSolutions

  Company1 trialPhase 462 people

• Red de Terapia Celular

  Company1 trialPhase 220 people

• Assistance Publique - Hôpitaux de Paris

  1 trialPhase 1/210 people

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  1 trialPhase 1/21 person

NIH Clinical CenterNational Institute on AgingUS$381.2kNational Institute of Allergy and Infectious DiseasesUS$73.6k

• Defining the Role of Dynamic X Chromosome Inactivation in Age-Associated B Cells for Female-Biased Systemic Lupus Erythematosus

  National Institute of Allergy and Infectious DiseasesUniversity of PennsylvaniaUS$37.1k2023–2026

• Tablet-Based Physical Activity Intervention for Frail and Pre-Frail Older Adults with Systemic Lupus Erythematosus

  National Institute on AgingHospital for Special SurgeryUS$193.3k2024–2029

• Elucidating the Role of Novel Aging-Associated ThA Cells in the Pathogenesis of Systemic Lupus Erythematosus

  Japan Society for the Promotion of ScienceUniversity of TokyoJP¥18.9m2025–2028

• Effect of interval training on serum adipokine levels in patients with systemic lupus erythematosus

  Fundacao de Amparo a Pesquisa do Estado de Sao PauloFederal University of São Paulo2019–2022

• Constructing and validating a frailty index as a novel measure of health status in patients with systemic lupus erythematosus (SLE)

  Canadian Institutes of Health Research (CIHR) Project GrantDalhousie UniversityCA$17.5k2017–2018

• Pilot Study Characterizing Aerobic Exercise in Women with Systemic Lupus Erythematosus (Exercise SLE Pilot)

  NIH Clinical CenterClinical Center